Tewodros Shibabaw

895 total citations
20 papers, 595 citations indexed

About

Tewodros Shibabaw is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Tewodros Shibabaw has authored 20 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Tewodros Shibabaw's work include Liver Disease Diagnosis and Treatment (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Tewodros Shibabaw is often cited by papers focused on Liver Disease Diagnosis and Treatment (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Tewodros Shibabaw collaborates with scholars based in Ethiopia, Australia and Rwanda. Tewodros Shibabaw's co-authors include Birhanu Ayelign, Meseret Derbew Molla, Yonas Akalu, Markos Negash, Gashaw Dessie, Zeleke Geto, Baye Dagnew, Tadesse Asmamaw Dejenie, Aschalew Gelaw and Endeshaw Chekol Abebe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Molecular and Cellular Biochemistry.

In The Last Decade

Tewodros Shibabaw

20 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tewodros Shibabaw Ethiopia 13 162 151 133 108 77 20 595
Natalia Muñoz‐Durango Chile 12 94 0.6× 137 0.9× 171 1.3× 202 1.9× 81 1.1× 15 760
Jianping Ma China 18 129 0.8× 166 1.1× 171 1.3× 280 2.6× 66 0.9× 58 924
Vsevolod Zinserling Russia 10 300 1.9× 110 0.7× 86 0.6× 67 0.6× 65 0.8× 47 639
Huang-Pin Wu Taiwan 16 76 0.5× 285 1.9× 156 1.2× 203 1.9× 65 0.8× 61 793
Camila Eleutério Rodrigues Brazil 14 90 0.6× 134 0.9× 208 1.6× 76 0.7× 128 1.7× 33 939
R.J. Bright-Thomas United Kingdom 19 111 0.7× 300 2.0× 134 1.0× 51 0.5× 98 1.3× 60 1.1k
Xiaosong Qin China 17 115 0.7× 120 0.8× 233 1.8× 56 0.5× 53 0.7× 77 897
Jinquan Wang China 14 361 2.2× 154 1.0× 177 1.3× 93 0.9× 64 0.8× 41 978
Nofri Rahmadika Indonesia 3 209 1.3× 195 1.3× 121 0.9× 76 0.7× 103 1.3× 5 776
Ki Tae Kim South Korea 19 83 0.5× 246 1.6× 153 1.2× 100 0.9× 206 2.7× 92 1.1k

Countries citing papers authored by Tewodros Shibabaw

Since Specialization
Citations

This map shows the geographic impact of Tewodros Shibabaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tewodros Shibabaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tewodros Shibabaw more than expected).

Fields of papers citing papers by Tewodros Shibabaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tewodros Shibabaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tewodros Shibabaw. The network helps show where Tewodros Shibabaw may publish in the future.

Co-authorship network of co-authors of Tewodros Shibabaw

This figure shows the co-authorship network connecting the top 25 collaborators of Tewodros Shibabaw. A scholar is included among the top collaborators of Tewodros Shibabaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tewodros Shibabaw. Tewodros Shibabaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shibabaw, Tewodros, et al.. (2025). Venous thromboembolism prevention practice and associated factors among orthopedic surgical patients in Ethiopia: a cross-sectional study. Hospital Practice. 53(1). 2503697–2503697. 1 indexed citations
2.
Shibabaw, Tewodros, et al.. (2024). Review of Asherman syndrome and its hysteroscopic treatment outcomes: experience in a low-resource setting. BMC Women s Health. 24(1). 99–99. 6 indexed citations
3.
Shibabaw, Tewodros, et al.. (2023). The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target. Frontiers in Immunology. 14. 1094823–1094823. 30 indexed citations
4.
Shibabaw, Tewodros, et al.. (2023). Hepatoprotective effect of hydromethanol extract of Otostegia integrifolia benth leaves in isoniazid and rifampicin induced Swiss albino mice. SHILAP Revista de lepidopterología. 20. 100255–100255. 3 indexed citations
5.
6.
Molla, Meseret Derbew, Abebe Bekele, Feyissa Challa, et al.. (2021). Hyperuricemia and Its Associated Factors Among Adult Staff Members of the Ethiopian Public Health Institute, Ethiopia. International Journal of General Medicine. Volume 14. 1437–1447. 5 indexed citations
7.
Dessie, Gashaw, Birhanu Ayelign, Yonas Akalu, Tewodros Shibabaw, & Meseret Derbew Molla. (2021). Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication. Diabetes Metabolic Syndrome and Obesity. Volume 14. 3307–3322. 31 indexed citations
8.
Shibabaw, Tewodros, et al.. (2021). Ketogenic Diets and their Therapeutic Potential on Breast Cancer: A Systemic Review. Cancer Management and Research. Volume 13. 9147–9155. 17 indexed citations
9.
Ayelign, Birhanu, Markos Negash, Andualem Henok, et al.. (2021). Association of IL-10 (− 1082 A/G) and IL-6 (− 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population. BMC Endocrine Disorders. 21(1). 70–70. 20 indexed citations
10.
11.
Dessie, Gashaw, Meseret Derbew Molla, Tewodros Shibabaw, & Birhanu Ayelign. (2020). <p>Role of Stem-Cell Transplantation in Leukemia Treatment</p>. PubMed. Volume 13. 67–77. 8 indexed citations
12.
Ayelign, Birhanu, et al.. (2020). <p>Helminth Induced Immunoregulation and Novel Therapeutic Avenue of Allergy</p>. Journal of Asthma and Allergy. Volume 13. 439–451. 18 indexed citations
13.
Shibabaw, Tewodros, et al.. (2020). <p>Role of IFN and Complements System: Innate Immunity in SARS-CoV-2</p>. Journal of Inflammation Research. Volume 13. 507–518. 31 indexed citations
14.
Molla, Meseret Derbew, Yonas Akalu, Zeleke Geto, et al.. (2020). <p>Role of Caspase-1 in the Pathogenesis of Inflammatory-Associated Chronic Noncommunicable Diseases</p>. Journal of Inflammation Research. Volume 13. 749–764. 72 indexed citations
15.
Shibabaw, Tewodros, et al.. (2020). <p>Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer</p>. Breast Cancer Targets and Therapy. Volume 12. 165–180. 8 indexed citations
16.
Shibabaw, Tewodros. (2020). <p>Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy</p>. Journal of Inflammation Research. Volume 13. 673–680. 77 indexed citations
17.
Shibabaw, Tewodros. (2020). Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease. Molecular and Cellular Biochemistry. 476(2). 993–1003. 56 indexed citations
18.
Shibabaw, Tewodros, et al.. (2019). Assessment of liver marker enzymes and its association with type 2 diabetes mellitus in Northwest Ethiopia. BMC Research Notes. 12(1). 707–707. 51 indexed citations
19.
Ayelign, Birhanu, et al.. (2019). Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis. Journal of Immunology Research. 2019. 1–8. 113 indexed citations
20.
Ayelign, Birhanu, et al.. (2017). Bacterial isolates and their antimicrobial susceptibility patterns among pediatric patients with urinary tract infections. SHILAP Revista de lepidopterología. 44(1). 62–69. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Muñoz‐Durango Breakdown of academic impact, for papers by Jianping Ma Breakdown of academic impact, for papers by Vsevolod Zinserling Breakdown of academic impact, for papers by Huang-Pin Wu Breakdown of academic impact, for papers by Camila Eleutério Rodrigues Breakdown of academic impact, for papers by R.J. Bright-Thomas Breakdown of academic impact, for papers by Xiaosong Qin Breakdown of academic impact, for papers by Jinquan Wang Breakdown of academic impact, for papers by Nofri Rahmadika Breakdown of academic impact, for papers by Ki Tae Kim
Rankless by CCL
2026